Anavex Life Sciences
AVXL
#7563
Rank
โ‚น35.31 B
Marketcap
โ‚น395.28
Share price
-1.12%
Change (1 day)
-38.58%
Change (1 year)

Anavex Life Sciences (AVXL) - Cash on Hand

Cash on Hand as of June 2025 : โ‚น9.08 Billion

According to Anavex Life Sciences 's latest financial reports the company has โ‚น9.08 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Anavex Life Sciences - Cash on Hand chart (from 2005 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-09-30โ‚น11.08 B-11.79%
2023-09-30โ‚น12.56 B3.47%
2022-09-30โ‚น12.14 B7.49%
2021-09-30โ‚น11.29 B423.92%
2020-09-30โ‚น2.15 B37.01%
2019-09-30โ‚น1.57 B-5.36%
2018-09-30โ‚น1.66 B-7.23%
2017-09-30โ‚น1.79 B191.84%
2016-09-30โ‚น0.61 B-38.71%
2015-09-30โ‚น1.00 B123.18%
2014-09-30โ‚น0.44 B1978.96%
2013-09-30โ‚น21.59 M3496.37%
2012-09-30โ‚น0.6 M-90.92%
2011-09-30โ‚น6.61 M-43.94%
2010-09-30โ‚น11.79 M-29.61%
2009-09-30โ‚น16.75 M5560.22%
2008-09-30โ‚น0.29 M29750.4%
2007-09-30โ‚น0 M-99.82%
2006-09-30โ‚น0.56 M1208.55%
2005-09-30โ‚น0.04 M-96.68%
2004-09-30โ‚น1.29 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚น60.81 B 569.15%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น19.12 B 110.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚น37.88 B 316.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚น0.22 B-97.51%๐Ÿ‡บ๐Ÿ‡ธ USA